{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:56:28Z","timestamp":1773334588157,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-04127-3","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:08:33Z","timestamp":1773292113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging markers and circulating biomarkers for predicting hemorrhage from cerebral cavernous malformations: A systematic review"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7282-9131","authenticated-orcid":false,"given":"Lidia","family":"Cheidde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio Yuri","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gean Carlo","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alleh","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Alexandre Gomes","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Paulo Ladeira","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Daniel Ferreira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F. Fabrini","family":"Paleare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Martinez-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon E.","family":"Bocanegra-Becerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafell","family":"Serulle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Netanel","family":"Ben-Shalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"12","key":"4127_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrneurol.2009.177","volume":"5","author":"S Batra","year":"2009","unstructured":"Batra S, Lin D, Recinos PF et al (2009) Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 5(12):659\u2013670. https:\/\/doi.org\/10.1038\/nrneurol.2009.177","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"4127_CR2","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/jcbfm.2015.98","volume":"35","author":"AG Mikati","year":"2015","unstructured":"Mikati AG, Khanna O, Zhang L et al (2015) Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab 35(10):1632\u20131639. https:\/\/doi.org\/10.1038\/jcbfm.2015.98","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"4127_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.3.JNS181724","volume":"131","author":"IA Awad","year":"2019","unstructured":"Awad IA, Polster SP (2019) Cavernous angiomas: deconstructing a neurosurgical disease. J Neurosurg 131(1):1\u201313. https:\/\/doi.org\/10.3171\/2019.3.JNS181724","journal-title":"J Neurosurg"},{"issue":"5","key":"4127_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/neuros\/nyx091","volume":"80","author":"A Akers","year":"2017","unstructured":"Akers A, Al-Shahi Salman R, Awad IA et al (2017) Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 80(5):665\u2013680. https:\/\/doi.org\/10.1093\/neuros\/nyx091","journal-title":"Neurosurgery"},{"issue":"9","key":"4127_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.mayocp.2019.11.005","volume":"95","author":"KD Flemming","year":"2020","unstructured":"Flemming KD, Lanzino G (2020) Cerebral cavernous malformation: what a practicing clinician should know. Mayo Clin Proc 95(9):2005\u20132020. https:\/\/doi.org\/10.1016\/j.mayocp.2019.11.005","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"4127_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1750-3639.2010.00441.x","volume":"21","author":"R D\u2019Angelo","year":"2011","unstructured":"D\u2019Angelo R, Marini V, Rinaldi C et al (2011) Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation. Brain Pathol 21(2):215\u2013224. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00441.x","journal-title":"Brain Pathol"},{"issue":"5","key":"4127_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ajmg.a.61519","volume":"182","author":"AK Manole","year":"2020","unstructured":"Manole AK, Forrester VJ, Zlotoff BJ et al (2020) Cutaneous findings of familial cerebral cavernous malformation syndrome due to the common Hispanic mutation. Am J Med Genet A 182(5):1066\u20131072. https:\/\/doi.org\/10.1002\/ajmg.a.61519","journal-title":"Am J Med Genet A"},{"key":"4127_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/B978-0-444-63640-9.00023-0","volume":"143","author":"HE Goldstein","year":"2017","unstructured":"Goldstein HE, Solomon RA (2017) Epidemiology of cavernous malformations. Handb Clin Neurol 143:241\u2013247. https:\/\/doi.org\/10.1016\/B978-0-444-63640-9.00023-0","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"4127_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.rx.2011.09.016","volume":"54","author":"JJ Cort\u00e9s Vela","year":"2012","unstructured":"Cort\u00e9s Vela JJ, Concepci\u00f3n Aramend\u00eda L, Ballenilla Marco F et al (2012) Cerebral cavernous malformations: spectrum of neuroradiological findings. Radiologia 54(5):401\u2013409. https:\/\/doi.org\/10.1016\/j.rx.2011.09.016","journal-title":"Radiologia"},{"key":"4127_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.wneu.2016.03.080","volume":"91","author":"P Dammann","year":"2016","unstructured":"Dammann P, Jabbarli R, Wittek P et al (2016) Solitary sporadic cerebral cavernous malformations: risk factors of first or recurrent symptomatic hemorrhage and associated functional impairment. World Neurosurg 91:73\u201380. https:\/\/doi.org\/10.1016\/j.wneu.2016.03.080","journal-title":"World Neurosurg"},{"issue":"1","key":"4127_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCRESAHA.121.318174","volume":"129","author":"DA Snellings","year":"2021","unstructured":"Snellings DA, Hong CC, Ren AA et al (2021) Cerebral cavernous malformation: from mechanism to therapy. Circ Res 129(1):195\u2013215. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318174","journal-title":"Circ Res"},{"key":"4127_CR12","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"7","key":"4127_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7326\/M22-0276","volume":"175","author":"J Lee","year":"2022","unstructured":"Lee J, Mulder F, Leeflang M et al (2022) QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies. Ann Intern Med 175(7):1010\u20131018. https:\/\/doi.org\/10.7326\/M22-0276","journal-title":"Ann Intern Med"},{"issue":"2","key":"4127_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000507789","volume":"49","author":"KD Flemming Jr","year":"2020","unstructured":"Flemming KD, Kumar S, Brown RD Jr et al (2020) Cavernous malformation hemorrhagic presentation at diagnosis associated with Low 25-Hydroxy-Vitamin D Level. Cerebrovasc Dis 49(2):216\u2013222. https:\/\/doi.org\/10.1159\/000507789","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"4127_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107462","volume":"33","author":"MS Jabal","year":"2024","unstructured":"Jabal MS, Mohammed MA, Kobeissi H et al (2024) Quantitative image signature and machine learning-based prediction of outcomes in cerebral cavernous malformations. J Stroke Cerebrovasc Dis 33(1):107462. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2023.107462","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4127_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jocn.2016.12.023","volume":"37","author":"S Noshiro","year":"2017","unstructured":"Noshiro S, Mikami T, Kataoka-Sasaki Y et al (2017) Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations. J Clin Neurosci 37:83\u201390. https:\/\/doi.org\/10.1016\/j.jocn.2016.12.023","journal-title":"J Clin Neurosci"},{"issue":"7","key":"4127_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3174\/ajnr.A4724","volume":"37","author":"H Tan","year":"2016","unstructured":"Tan H, Zhang L, Mikati AG et al (2016) Quantitative susceptibility mapping in cerebral cavernous malformations: clinical correlations. AJNR Am J Neuroradiol 37(7):1209\u20131215. https:\/\/doi.org\/10.3174\/ajnr.A4724","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"4127_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/jmri.27935","volume":"55","author":"JY Sone","year":"2022","unstructured":"Sone JY, Hobson N, Srinath A et al (2022) Perfusion and permeability MRI predicts future cavernous angioma hemorrhage and growth. J Magn Reson Imaging 55(5):1440\u20131449. https:\/\/doi.org\/10.1002\/jmri.27935","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"4127_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2217\/bmm.15.118","volume":"10","author":"R Girard","year":"2016","unstructured":"Girard R, Khanna O, Shenkar R et al (2016) Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med 10(3):255\u2013264. https:\/\/doi.org\/10.2217\/bmm.15.118","journal-title":"Biomark Med"},{"issue":"1","key":"4127_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3171\/2016.5.JNS16687","volume":"127","author":"R Girard","year":"2017","unstructured":"Girard R, Fam MD, Zeineddine HA et al (2017) Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations. J Neurosurg 127(1):102\u2013110. https:\/\/doi.org\/10.3171\/2016.5.JNS16687","journal-title":"J Neurosurg"},{"issue":"1","key":"4127_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12975-017-0561-3","volume":"9","author":"R Girard","year":"2018","unstructured":"Girard R, Zeineddine HA, Fam MD et al (2018) Plasma biomarkers of inflammation reflect seizures and hemorrhagic activity of cerebral cavernous malformations. Transl Stroke Res 9(1):34\u201343. https:\/\/doi.org\/10.1007\/s12975-017-0561-3","journal-title":"Transl Stroke Res"},{"issue":"12","key":"4127_CR22","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1161\/CIRCRESAHA.118.312680","volume":"122","author":"R Girard","year":"2018","unstructured":"Girard R, Zeineddine HA, Koskim\u00e4ki J et al (2018) Plasma biomarkers of inflammation and angiogenesis predict cerebral cavernous malformation symptomatic hemorrhage or lesional growth. Circ Res 122(12):1716\u20131721. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312680","journal-title":"Circ Res"},{"issue":"1","key":"4127_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/STROKEAHA.123.044083","volume":"55","author":"S Hage","year":"2024","unstructured":"Hage S, Kinkade S, Girard R et al (2024) Trial readiness of cavernous malformations with symptomatic hemorrhage, Part II: biomarkers and trial modeling. Stroke 55(1):31\u201339. https:\/\/doi.org\/10.1161\/STROKEAHA.123.044083","journal-title":"Stroke"},{"issue":"5","key":"4127_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167139","volume":"1870","author":"S Jauhiainen","year":"2024","unstructured":"Jauhiainen S, Onyeogaziri FC, Lazzaroni F et al (2024) Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870(5):167139. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167139","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"4127_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JIR.S63898","volume":"7","author":"K Yin","year":"2014","unstructured":"Yin K, Agrawal DK (2014) Vitamin D and inflammatory diseases. J Inflamm Res 7:69\u201387. https:\/\/doi.org\/10.2147\/JIR.S63898","journal-title":"J Inflamm Res"},{"key":"4127_CR26","doi-asserted-by":"publisher","unstructured":"Zhang Z, Deng J, Sun W, et al. (2025) Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy. Brain Behav 15(1):e70223. https:\/\/doi.org\/10.1002\/brb3.70223","DOI":"10.1002\/brb3.70223"},{"issue":"3","key":"4127_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","volume":"131","author":"CC Gibson","year":"2015","unstructured":"Gibson CC, Zhu W, Davis CT et al (2015) Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131(3):289\u2013299. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010403","journal-title":"Circulation"},{"key":"4127_CR28","doi-asserted-by":"publisher","unstructured":"Previch L, Lanzino G, Brown RD Jr et al (2022) The influence of select medications on prospective hemorrhage risk in patients with spinal or cerebral cavernous malformations. World Neurosurg 163:e678\u2013e683. https:\/\/doi.org\/10.1016\/j.wneu.2022.03.101","DOI":"10.1016\/j.wneu.2022.03.101"},{"issue":"4","key":"4127_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10456-020-09736-8","volume":"23","author":"MR Detter","year":"2020","unstructured":"Detter MR, Shenkar R, Benavides CR et al (2020) Novel murine models of cerebral cavernous malformations. Angiogenesis 23(4):651\u2013666. https:\/\/doi.org\/10.1007\/s10456-020-09736-8","journal-title":"Angiogenesis"},{"issue":"5","key":"4127_CR30","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1182\/blood.V88.5.1583.1583","volume":"88","author":"JR Toomey","year":"1996","unstructured":"Toomey JR, Kratzer KE, Lasky NM et al (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88(5):1583\u20131587","journal-title":"Blood"},{"issue":"6595","key":"4127_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/383073a0","volume":"383","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet P, Mackman N, Moons L et al (1996) Role of tissue factor in embryonic blood vessel development. Nature 383(6595):73\u201375. https:\/\/doi.org\/10.1038\/383073a0","journal-title":"Nature"},{"issue":"20","key":"4127_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012575","volume":"23","author":"MA Globisch","year":"2022","unstructured":"Globisch MA, Onyeogaziri FC, Smith RO et al (2022) Dysregulated hemostasis and immunothrombosis in cerebral cavernous malformations. Int J Mol Sci 23(20):12575. https:\/\/doi.org\/10.3390\/ijms232012575","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4127_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/bj2650621","volume":"265","author":"PC Heinrich","year":"1990","unstructured":"Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265(3):621\u2013636. https:\/\/doi.org\/10.1042\/bj2650621","journal-title":"Biochem J"},{"issue":"3","key":"4127_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s1074-7613(00)80334-9","volume":"6","author":"M Romano","year":"1997","unstructured":"Romano M, Sironi M, Toniatti C et al (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6(3):315\u2013325. https:\/\/doi.org\/10.1016\/s1074-7613(00)80334-9","journal-title":"Immunity"},{"issue":"2","key":"4127_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1128\/mcb.13.2.1183-1193.1993","volume":"13","author":"J Dalmon","year":"1993","unstructured":"Dalmon J, Laurent M, Courtois G (1993) The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol 13(2):1183\u20131193. https:\/\/doi.org\/10.1128\/mcb.13.2.1183-1193.1993","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4127_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ana.20697","volume":"59","author":"Y Chen","year":"2006","unstructured":"Chen Y, Pawlikowska L, Yao JS et al (2006) Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59(1):72\u201380. https:\/\/doi.org\/10.1002\/ana.20697","journal-title":"Ann Neurol"},{"issue":"2","key":"4127_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000317106","volume":"30","author":"S Okazaki","year":"2010","unstructured":"Okazaki S, Furukado S, Abe Y et al (2010) Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients. Cerebrovasc Dis 30(2):180\u2013187. https:\/\/doi.org\/10.1159\/000317106","journal-title":"Cerebrovasc Dis"},{"issue":"9","key":"4127_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13091336","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Srinath A, Alcazar-Felix RJ et al (2023) Inflammatory mechanisms in a neurovascular disease: cerebral cavernous malformation. Brain Sci 13(9):1336. https:\/\/doi.org\/10.3390\/brainsci13091336","journal-title":"Brain Sci"},{"key":"4127_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.wneu.2019.02.115","volume":"126","author":"S Taslimi","year":"2019","unstructured":"Taslimi S, Ku JC, Modabbernia A et al (2019) Hemorrhage, seizures, and dynamic changes of familial versus nonfamilial cavernous malformation: systematic review and meta-analysis. World Neurosurg 126:241\u2013246. https:\/\/doi.org\/10.1016\/j.wneu.2019.02.115","journal-title":"World Neurosurg"},{"issue":"2","key":"4127_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000185609","volume":"27","author":"H Kim","year":"2009","unstructured":"Kim H, Hysi PG, Pawlikowska L et al (2009) Common variants in interleukin-1-beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis 27(2):176\u2013182. https:\/\/doi.org\/10.1159\/000185609","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"4127_CR41","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.4049\/jimmunol.0901511","volume":"183","author":"Y Carmi","year":"2009","unstructured":"Carmi Y, Voronov E, Dotan S et al (2009) The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol 183(7):4705\u20134714. https:\/\/doi.org\/10.4049\/jimmunol.0901511","journal-title":"J Immunol"},{"issue":"11","key":"4127_CR42","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.122.321129","volume":"131","author":"CC Lai","year":"2022","unstructured":"Lai CC, Nelsen B, Frias-Anaya E et al (2022) Neuroinflammation plays a critical role in cerebral cavernous malformation disease. Circ Res 131(11):909\u2013925. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321129","journal-title":"Circ Res"},{"key":"4127_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","volume":"52","author":"A Vander Ark","year":"2018","unstructured":"Vander Ark A, Cao J, Li X (2018) TGF-\u03b2 receptors: in and beyond TGF-\u03b2 signaling. Cell Signal 52:112\u2013120. https:\/\/doi.org\/10.1016\/j.cellsig.2018.09.002","journal-title":"Cell Signal"},{"key":"4127_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.567682","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yang X (2020) The roles of TGF-\u03b2 signaling in cerebrovascular diseases. Front Cell Dev Biol 8:567682. https:\/\/doi.org\/10.3389\/fcell.2020.567682","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"4127_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005149","volume":"4","author":"TE Walshe","year":"2009","unstructured":"Walshe TE, Saint-Geniez M, Maharaj AS et al (2009) TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One 4(4):e5149. https:\/\/doi.org\/10.1371\/journal.pone.0005149","journal-title":"PLoS One"},{"issue":"1","key":"4127_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000356839","volume":"37","author":"H Choquet","year":"2014","unstructured":"Choquet H, Nelson J, Pawlikowska L et al (2014) Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis 37(1):57\u201363. https:\/\/doi.org\/10.1159\/000356839","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"4127_CR47","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1161\/STROKEAHA.120.031569","volume":"52","author":"B Chen","year":"2021","unstructured":"Chen B, Saban D, Rauscher S et al (2021) Modifiable cardiovascular risk factors in patients with sporadic cerebral cavernous malformations: obesity matters. Stroke 52(4):1259\u20131264. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031569","journal-title":"Stroke"},{"issue":"2\u20133","key":"4127_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mvr.2007.03.004","volume":"74","author":"AS Maharaj","year":"2007","unstructured":"Maharaj AS, D\u2019Amore PA (2007) Roles for VEGF in the adult. Microvasc Res 74(2\u20133):100\u2013113. https:\/\/doi.org\/10.1016\/j.mvr.2007.03.004","journal-title":"Microvasc Res"},{"issue":"8","key":"4127_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083794","volume":"26","author":"RJ Alcazar-Felix","year":"2025","unstructured":"Alcazar-Felix RJ, Jhaveri A, Iqbal J et al (2025) A systematic review of microRNAs in hemorrhagic neurovascular disease: cerebral cavernous malformations as a paradigm. Int J Mol Sci 26(8):3794. https:\/\/doi.org\/10.3390\/ijms26083794","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4127_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/jon.13072","volume":"33","author":"D Kuroedov","year":"2023","unstructured":"Kuroedov D, Cunha B, Pamplona J et al (2023) Cerebral cavernous malformations: typical and atypical imaging characteristics. J Neuroimaging 33(2):202\u2013217. https:\/\/doi.org\/10.1111\/jon.13072","journal-title":"J Neuroimaging"},{"key":"4127_CR51","doi-asserted-by":"publisher","unstructured":"Zeineddine HA, Girard R, Cao Y, et al. (2018) Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. J Magn Reson Imaging 47(4):1133\u20131138. https:\/\/doi.org\/10.1002\/jmri.25831","DOI":"10.1002\/jmri.25831"},{"issue":"9","key":"4127_CR52","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/WNL.0b013e31824a78a0","volume":"78","author":"R Al-Shahi Salman","year":"2012","unstructured":"Al-Shahi Salman R, Murray GD (2012) The next step in understanding the prognosis of cerebral cavernous malformations. Neurology 78(9):614\u2013615. https:\/\/doi.org\/10.1212\/WNL.0b013e31824a78a0","journal-title":"Neurology"},{"issue":"12","key":"4127_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128577","volume":"4","author":"SB Lyne","year":"2019","unstructured":"Lyne SB, Girard R, Koskim\u00e4ki J et al (2019) Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight 4(12):e128577. https:\/\/doi.org\/10.1172\/jci.insight.128577","journal-title":"JCI Insight"},{"key":"4127_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104914","volume":"99","author":"F Lazzaroni","year":"2024","unstructured":"Lazzaroni F, Meessen JMTA, Sun Y et al (2024) Circulating biomarkers in familial cerebral cavernous malformation. EBioMedicine 99:104914. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104914","journal-title":"EBioMedicine"},{"issue":"6","key":"4127_CR55","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1177\/0271678X251314366","volume":"45","author":"SF Hage","year":"2025","unstructured":"Hage SF, Bi DE, Kinkade S et al (2025) Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformations. J Cereb Blood Flow Metab 45(6):1153\u20131165. https:\/\/doi.org\/10.1177\/0271678X251314366","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-04127-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:08:34Z","timestamp":1773292114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-04127-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4127"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-04127-3","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors report no relationships that could be construed as a conflict of interest.\u00a0All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this is a systematic review per PRISMA Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not relevant, as no individual patient data was used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consent to publication, and this study has not been accepted for publication elsewhere.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable as this is a systematic review per PRISMA Guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}